Pharmacology for Nurses · Psychopharmacologic Drugs
Anxiolytics and Sedative-Hypnotics
On this page 9 sections
In 30 seconds
Anxiolytics reduce anxiety; sedative-hypnotics promote calm and sleep. The two jobs overlap so heavily that the same drugs often do both — the difference is mostly dose and timing: a small dose of a calming drug may relieve daytime anxiety, while a larger dose of the same drug produces sleep. Because of that overlap, this topic treats the group as one family with shared mechanisms, risks, and nursing concerns.
The main classes are the benzodiazepines (the workhorse anxiolytics), the barbiturates (older, now used sparingly because of their danger in overdose), the Z-drugs (non-benzodiazepine hypnotics mainly for insomnia), and Buspirone Serotonin (5-HT1A) partial-agonist anxiolytic Full entry → (a non-sedating anxiolytic with a different mechanism). The unifying theme is the brain's inhibitory system: most of these drugs work by strengthening the calming signal of the neurotransmitter GABA The main inhibitory neurotransmitter; quiets neuronal firing Full entry → (gamma-aminobutyric acid).
Why this matters
Anxiety and insomnia are among the most common complaints in health care, and drugs that quiet the brain carry steep safety stakes. They cause sedation, impaired coordination, and slowed breathing — translating directly into falls, fractures, and, combined with alcohol or other depressants, life-threatening respiratory depression. They also produce tolerance, dependence, and withdrawal, so stopping abruptly can be more dangerous than continuing. The nurse's job: assess baseline mental status and vital signs, monitor sedation, protect the person from falls, teach about alcohol interactions and withdrawal risk, and support a slow, provider-directed taper when the drug is no longer needed.
The college version
Core Concepts
GABA: the brain's brake pedal
GABA is the main inhibitory neurotransmitter: when it binds its receptors, neurons become less likely to fire, quieting neural circuits. The GABA-A receptor A chloride channel that makes neurons harder to excite Full entry → is a chloride channel; when GABA opens it, the neuron is harder to excite — like pressing a brake. Most sedative-hypnotics act here:
- Benzodiazepines bind a specific site on the GABA-A receptor and make GABA's braking effect stronger. They do not open the channel by themselves — they amplify the natural signal. This is why they are relatively safe alone in overdose: with no GABA activity, there is less to amplify.
- Barbiturates bind a different site and can open the chloride channel directly, even without GABA. That direct action makes them potent — and lethal in overdose, because at high doses they can stop breathing on their own. Their narrow therapeutic index is why they have largely been replaced.
- Z-drugs bind the Benzodiazepine Anxiolytic class that amplifies GABA Full entry → site but were designed mainly as sleep agents. They are still CNS depressants with the same core risks.
Benzodiazepines: shared effects, different speeds
All benzodiazepines produce the same menu: anxiolysis, sedation, muscle relaxation, anticonvulsant action, and anterograde amnesia (difficulty forming new memories while the drug is active). They differ mainly in speed and duration: short- and intermediate-acting agents are often chosen for insomnia or situational anxiety; long-acting agents provide steadier coverage but accumulate, especially in older adults with slower clearance, causing morning-after sedation and higher fall risk.
All benzodiazepines are controlled substances. With sustained use, tolerance (needing more for the same effect) and physical dependence (withdrawal on stopping) are expected pharmacologic consequences — not signs of a "bad" patient. The antagonist Flumazenil Benzodiazepine-site antagonist Full entry → can reverse excessive sedation, but it is used with great caution: in a person physically dependent on benzodiazepines, it can precipitate dangerous withdrawal, including seizures.
Barbiturates: the history lesson
Barbiturates were the dominant sedative-hypnotics for much of the 20th century. Their ability to open the chloride channel directly gives them a narrow therapeutic index: the dose that causes sleep is uncomfortably close to the dose that stops breathing, and combining them with alcohol or opioids is especially deadly. They also induce liver enzymes, speeding the metabolism of other drugs. Today they are limited to specific situations (some seizure emergencies, anesthesia) under close monitoring — and they remain an exam favorite for the concept of dose-dependent CNS depression.
Buspirone: the non-sedating option
Buspirone does not act on GABA at all; it is a partial agonist at serotonin (5-HT1A) receptors. The consequences are huge: little to no sedation, no muscle relaxation, minimal abuse potential, and no dangerous alcohol interaction. The trade-offs: it takes 1–3 weeks to work (useless for a panic attack right now) and must be taken regularly, not as needed.
Nursing care across the class
- Assessment: level of consciousness, sedation, respiratory rate and depth, blood pressure, gait, and mental status. Slowing respirations or increasing sedation is a red flag, especially with alcohol or an opioid on board.
- Fall prevention: these drugs impair coordination. Call light within reach, assistance with ambulation, and nonslip footwear are routine, especially at night.
- Teaching: no alcohol or other CNS depressants without provider guidance; no driving until effects are known; never stop suddenly — withdrawal can be severe (anxiety, tremor, and in serious cases seizures), so discontinuation is tapered by the provider.
- Older adults: more sensitive to sedation, falls, and memory effects; lower starting doses and careful reassessment are standard, and non-drug approaches are tried first when appropriate. Scope and institutional variation apply — what the nurse initiates, monitors, and teaches follows facility policy, state regulations, and prescriber orders; verify against current references and the formulary.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Anxiolytics and sedative-hypnotics being different drug families | The same drugs at different doses | Benzodiazepines do both; dose and timing determine the effect |
| Benzodiazepines and barbiturates being equally dangerous | Their different mechanisms | Benzos only amplify GABA; barbiturates open the channel directly → narrower safety margin |
| Z-drugs being "safer, not depressants" | Other sedative-hypnotics | Same benzodiazepine site and the same sedation, fall, dependence, and withdrawal risks |
| Tolerance being addiction | A normal pharmacologic adaptation | Tolerance and dependence are expected consequences, not moral failings |
| Stopping a sedative abruptly being safe | The need for a taper | Abrupt withdrawal can cause rebound anxiety, insomnia, tremor, and seizures |
| Flumazenil being a universal antidote | A high-risk reversal agent | Can precipitate severe withdrawal seizures in dependent people; used only per protocols and orders |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your brain has a brake pedal called GABA that slows down your thoughts and movements. Anxiety medicines press that brake a little, which helps you feel calm; sleep medicines press it harder, which helps you fall asleep. Some are gentle and safe, but a few older ones are like pressing the brake so hard the car stalls — that's why they're only used in special situations. If you use the brake every day, your brain gets used to it, so stopping suddenly can make things worse, and mixing these medicines with alcohol is very dangerous.
Worked example
Mrs. Chen, age 74, was started on a long-acting benzodiazepine for generalized anxiety months ago and is now hospitalized after a hip fracture from getting up at night. The night nurse gives her ordered sedative and notices she is more confused than baseline, with a slower respiratory rate. The nurse reasons from the mechanism: the benzodiazepine amplifies GABA's braking effect, and in an older adult with slower drug clearance the effect accumulates — sedation deepens, coordination worsens, fall risk climbs. She places the call light within reach, reminds Mrs. Chen to call before getting up, checks sedation and respirations more frequently, and reports her findings to the provider, who reviews the plan — possibly a lower dose, a shorter-acting agent, or a taper, per orders and facility policy. She documents the teaching: no alcohol, no sudden stopping, and a provider discussion before any change. The lesson: this is not "just a sleeping pill" — it is a brake pedal on the whole nervous system, and the nurse monitors how hard it is pressing.
Key takeaways
- The same drugs do both jobs — dose and timing separate anxiolytic from hypnotic effects.
- Benzodiazepines amplify GABA's braking effect; they do not open the channel alone, making them safer in overdose than barbiturates.
- Barbiturates can open the chloride channel directly → potent but narrow therapeutic index and lethal in overdose → mostly replaced.
- Z-drugs act at the benzodiazepine site but target sleep; still CNS depressants with fall, dependence, and withdrawal risks.
- Buspirone works on serotonin, not GABA → non-sedating, no dependence, but takes 1–3 weeks; not for acute panic.
- Common benzodiazepine effects: anxiolysis, sedation, muscle relaxation, anticonvulsant action, anterograde amnesia.
- Tolerance, dependence, and withdrawal are expected with sustained use; abrupt discontinuation can cause rebound anxiety, insomnia, tremor, and seizures — tapers are provider-directed.
- Flumazenil reverses benzodiazepine sedation but may precipitate withdrawal seizures in dependent people — protocol- and order-driven.
- Nursing priorities: sedation/respiratory monitoring, fall prevention, alcohol-interaction teaching, no abrupt stopping, extra caution in older adults.
- No doses or schedules are given here — verify all specifics against current references, the formulary, and prescriber orders.
Check yourself
5 review questions from the chapter. Try each one, then open the answer.
How do benzodiazepines and barbiturates differ at the GABA-A receptor, and why does that matter for overdose safety?
Show answer
Benzodiazepines amplify the effect of GABA that is already present; barbiturates can open the chloride channel directly, even without GABA. Because barbiturates act alone, they can depress the CNS — including breathing — to lethal depths more easily: a narrow therapeutic index.
What is the relationship between anxiolytic and sedative-hypnotic effects?
Show answer
They are overlapping effects of the same class: a low dose tends to reduce anxiety while a higher dose of the same drug promotes sleep. Dose and timing determine which effect dominates.
Why is abrupt benzodiazepine discontinuation dangerous, and how is it managed?
Show answer
The brain adapts (physical dependence), so stopping suddenly removes the brake abruptly — causing rebound anxiety, insomnia, tremor, and potentially seizures. Discontinuation is tapered gradually under provider direction.
A patient asks for medication to "calm me down right now." Why would buspirone be a poor choice?
Show answer
Buspirone takes 1–3 weeks to work because it slowly adjusts serotonin signaling; it cannot relieve an acute surge of anxiety in minutes.
List three nursing priorities for a patient newly started on a benzodiazepine.
Show answer
Sedation and respiratory monitoring; fall prevention (call light, assistance); teaching about alcohol and CNS-depressant interactions and no abrupt stopping; cautious assessment in older adults (specifics per orders and facility policy).
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Anxiolytic / sedative-hypnotic
- Drugs that reduce anxiety / promote sleep
- GABA
- The main inhibitory neurotransmitter; quiets neuronal firing
- GABA-A receptor
- A chloride channel that makes neurons harder to excite
- Benzodiazepine
- Anxiolytic class that amplifies GABA
- Barbiturate
- Older CNS depressant that can directly open chloride channels
- Z-drug
- Non-benzodiazepine hypnotic acting at the benzodiazepine site
- Buspirone
- Serotonin (5-HT1A) partial-agonist anxiolytic
- Flumazenil
- Benzodiazepine-site antagonist
- Tolerance / dependence
- Needing more for the same effect / withdrawal on stopping
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.